NCT05025072View on ClinicalTrials.gov

A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 22, 2021

Primary Completion Date

September 29, 2021

Study Completion Date

September 29, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Hydroxycarbamide dispersible tablets

Hydroxycarbamide dispersible tablets (20 x 50 mg)

DRUG

Hydroxycarbamide film-coated tablet

Hydroxycarbamide film-coated tablet (1000 mg)

Trial Locations (1)

Unknown

Simbec-Orion Clinical Pharmacology, Merthyr Tydfil

Sponsors

Lead Sponsor

Theravia
All Listed Sponsors
collaborator

Simbec-Orion Group

INDUSTRY

collaborator

Oncodesign SA

INDUSTRY

collaborator

PhinC Development

INDUSTRY

lead

Theravia

INDUSTRY